<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>Astrazeneca疫苗：美国试验中79％有效，没有罕见的血栓 AstraZeneca vaccine: 79% effective and no rare blood clots in US trial</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">AstraZeneca vaccine: 79% effective and no rare blood clots in US trial<br/>Astrazeneca疫苗：美国试验中79％有效，没有罕见的血栓 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-03-23 02:56:45</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/3/c1f1beb8c3a857d23a90427b5d7c62d3.jpeg"><img src="http://img2.diglog.com/img/2021/3/c1f1beb8c3a857d23a90427b5d7c62d3.jpeg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Exceeding expectations, AstraZeneca’s two-dose COVID-19 vaccine appeared highly effective against symptomatic and severe disease in a new late-stage trial conducted partly in the US. The company said it is now seeking emergency use authorization from the Food and Drug Administration. However, the vaccine may still be dogged by doubts.</p><p>超出预期，阿斯利康的两剂Covid-19疫苗在部分在美国部分进行的新的后期试验中出现了对症状和严重疾病的高度有效。该公司表示，它正在寻求食品和药物管理局的紧急使用授权。然而，疫苗仍可能被怀疑令人痛苦。</p><p> The Phase III trial conducted in the US, Peru, and Chile found that the vaccine was 79 percent effective at preventing symptomatic disease,  the company reported early Monday. Previous trial results suggest efficacy could be as low as  62 percent.</p><p> 公司在周一早些时候报告，美国秘鲁和智利在美国，秘鲁和智利进行的III阶段试验发现，疫苗在预防症状疾病中有效。以前的试验结果表明疗效可能低至62％。</p><p> In the new 32,449-person trial, two-thirds of participants were dosed with the vaccine while the remaining third were given a placebo. There were  five cases of severe disease in the trial, all in the placebo group. None of the vaccinated participants required hospitalization.</p><p> 在新的32,449人试验中，三分之二的参与者用疫苗给药，而剩余的第三个参与者给予安慰剂。试验中有五种严重疾病，全部在安慰剂组中。没有疫苗接种的参与者需要住院治疗。</p><p> Notably, the company also found no increased risk of blood clotting events or cases of a rare, life-threatening blood clotting event, called CVST, among those vaccinated.</p><p> 值得注意的是，该公司还发现血液凝固事件或罕见的寿命血液凝固事件的风险增加，患有偏远的终身血液凝固事件，其中包括疫苗的疫苗。</p><p>  A small number of serious blood clotting events in people recently vaccinated sparked widespread concern in Europe and other countries, where the vaccine is already authorized for use. In the last week or so, more than a dozen countries—including Germany, France, Italy, and Spain—temporarily halted their rollouts of AstraZeneca’s vaccine, which was developed in collaboration with the University of Oxford.</p><p>  最近接种疫苗的人中少数严重的血液凝固事件引发了欧洲和其他国家的广泛关注，疫苗已被授权使用。在上周左右，在包括德国，法国，意大利和西班牙在内的十几个国家 - 暂时停止了他们的疫苗的推出，该疫苗是与牛津大学合作制定的。</p><p> Among the more than 20 million people who have already received the vaccine in the European Union and the United Kingdom, there have been at least 18 reported cases of CVST (cerebral venous sinus thrombosis), in which a clot prevents blood from draining from the brain, leading to a stroke. There were also at least seven other cases of people developing blood clots in multiple blood vessels, a condition called disseminated intravascular coagulation, or DIC. Nine of the CVST and DIC cases resulted in death.</p><p> 在已经收到欧盟和英国的超过2000万人中，至少有18例CVST（脑静脉窦血栓形成）的病例，其中凝块阻止血液从大脑中排出，导致中风。还有七种其他人在多种血管中开发血液凝块，一种称为传播血管内凝血或DIC的病症。九个CVST和DIC病例导致死亡。</p><p>    Last week,  the World Health Organization and the  European Medicines Agency independently reviewed all the data in detail and, in the end,  urged countries to quickly resume use of the vaccine. Both agencies concluded that the risks of severe disease and death from COVID-19 clearly outweighed the exceedingly rare risk of blood clotting events.</p><p>    上周，世界卫生组织和欧洲药物局的独立审查了所有数据，并敦促各国迅速恢复使用疫苗。两家机构得出结论，Covid-19严重疾病和死亡的风险显然超过了血液凝固事件的极少数风险。 </p><p> The WHO and the EMA noted that among the millions of vaccinated people, reports of blood clotting events—which are generally common—were lower than what would have been expected in the general population. They also couldn’t establish whether the vaccine caused the cases of CVST or DIC. But they couldn’t rule out the possibility, either, particularly since most of the cases were in people under the age of 55.</p><p>世卫组织和EMA指出，在数百万疫苗的人中，血液凝血事件的报道 - 这通常是普遍的普遍 - 普遍存在的群体。它们也无法建立疫苗是否导致CVST或DIC的病例。但他们不能排除可能性，特别是因为大多数案件都在55岁以下的人。</p><p>  Based on pre-COVID figures, it was calculated that less than 1 reported case of DIC might have been expected by 16 March among people under 50 within 14 days of receiving the vaccine, whereas 5 cases had been reported. Similarly, on average 1.35 cases of CVST might have been expected among this age group whereas by the same cut-off date there had been 12. A similar imbalance was not visible in the older population given the vaccine.</p><p>  根据预科图数据，计算出在接受疫苗后的14天内，50人不到5例，在3月16日的人们中，预计将预计DIC的案例少于1例，而据报道5例。同样，在这个年龄组中，在这个年龄组中可能预计平均1.35例CVST可能会有12岁的截止日期。患有疫苗的老年人口中不可见类似的不平衡。</p><p>  The new trial results didn’t find any cases of CVST, but— if there really is a link—this isn’t surprising based on the extremely low frequency of these events. The trial data included safety data for just about 21,500 vaccinated people, whereas the small number of cases outside of the trial occurred among upward of 20 million vaccinated people.</p><p>  新的试验结果没有找到任何CVST的情况，但是 - 如果确实存在链接 - 基于这些事件的极低频率并不令人惊讶。试验数据包括仅为21,500名疫苗的人员的安全数据，而审判之外的少数案件发生在2000万疫苗的疫苗中。</p><p> While there’s the real possibility that the cases are simply a statistical fluke,  some researchers hypothesize that the vaccine may—rarely—spark an autoimmune reaction that explains the illnesses, and they have suggested possible treatments along those lines. Other researchers have also noted that a link between the vaccine and blood clotting events is not implausible; COVID-19 itself is linked to blood clotting disorders, and research suggests that the SARS-CoV-2 spike protein can activate immune responses that  can lead to clotting.</p><p> 虽然案件只是一种统计侥幸的实际可能性，但一些研究人员假设疫苗可能很少 - 引发解释疾病的自身免疫反应，并且他们提出了这些系列的可能治疗。其他研究人员还注意到疫苗和血液凝固事件之间的联系并不难以置信; Covid-19本身与血液凝结障碍相关联，研究表明SARS-COV-2穗蛋白可以激活可导致凝血的免疫应答。</p><p>    But it will take much more data to firmly make the connection (if there is one), as well as figure out how such a reaction is sparked by the vaccine, and who might be affected. Like the other authorized COVID-19 vaccines, the AstraZeneca vaccine delivers to cells only the genetic code for the SARS-CoV-2 spike protein, which can train immune responses to target the virus. The vaccine does this using a non-replicating adenovirus as packaging, similar to the Johnson &amp; Johnson vaccine, which was  the latest vaccine authorized by the FDA.</p><p>    但它需要更多的数据来牢固地建立联系（如果有一个），以及弄清楚如何由疫苗引发这种反应，谁可能受到影响。与其他授权的Covid-19疫苗一样，AstraZeneca疫苗只能为细胞提供SARS-COV-2穗蛋白的遗传密码，这可以培训免疫应答来靶向病毒。疫苗使用非复制的腺病毒作为包装，类似于Johnson＆amp;约翰逊疫苗，这是FDA授权的最新疫苗。</p><p> For now, eyes will be on the FDA as it reviews the data and decides whether to grant an EUA. The agency is likely to look favorably on the efficacy and safety data of the new trial and see the vaccine as yet another useful tool in the fight against SARS-CoV-2. Still, gaining public support may be a bigger hurdle for the vaccine moving forward. Aside from the blood clotting concerns, the vaccine has experienced stumble after stumble in its clumsy development—from highly publicized  trial pauses due to unexplained illnesses and puzzling  dosing errors in some participants, to recent data suggesting it  may be useless against mild-to-moderate COVID-19 caused by the B.1.351 variant.</p><p> 目前，眼睛将在FDA上审查数据并决定是否授予EUA。原子能机构可能对新试验的疗效和安全数据看起来有利，看看疫苗，又称违反SARS-COV-2的另一个有用工具。尽管如此，公共支持可能是向前移动的疫苗更大的障碍。除了血液凝结问题外，疫苗在笨拙的发展中绊倒了困难 - 从高度公布的审判暂停，由于一些参与者的未解释的疾病和令人困惑的给药错误，到最近的数据表明它可能无用于温和至中等Covid-19由B.1.351变体引起。 </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://arstechnica.com/science/2021/03/astrazeneca-vaccine-79-effective-and-no-rare-blood-clots-in-us-trial/">https://arstechnica.com/science/2021/03/astrazeneca-vaccine-79-effective-and-no-rare-blood-clots-in-us-trial/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/美国/">#美国</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/疫苗/">#疫苗</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/rare/">#rare</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy;2012-2021 diglog.com </div></div></body></html>